CooperSurgical
This article was originally published in The Gray Sheet
Executive Summary
Womens healthcare product line acquired Jan. 31 from German company Leisegang Medical for $10.5 mil. includes colposcopes, loop electrosurgical excision instruments, gynecological and cyrosurgical instruments and the Sani-Spec disposable plastic specula. The products generate over $11 mil. in annual sales, and the purchase is expected to be accretive to CooperSurgical (CSI) parent Cooper Companies' fiscal 2000 earnings. CSI's annual revenues are expected to top $50 mil. with the new addition
You may also be interested in...
Cooper Gains Mityvac Vacuum-Assisted Delivery Offering Via Prism Purchase
Cooper Companies' CooperSurgical women's healthcare unit will add vacuum-assisted delivery (VAD) to its obstetrics franchise through the $23 mil. purchase of Prism Enterprises
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.